Ito Yukiko, Tsujino Takeshi, Togawa Osamu, Yamamoto Natsuyo, Isayama Hiroyuki, Nakata Ryo, Kawabe Takao, Omata Masao
Department of Gastroenterology, Japanese Red Cross Medical Center, University of Tokyo, Japan.
Gastrointest Endosc. 2008 Sep;68(3):477-82. doi: 10.1016/j.gie.2007.10.066.
Endoscopic papillary balloon dilation (EPBD) is a possible alternative to endoscopic sphincterotomy for the treatment of bile duct stones. However, little information is available in the elderly.
Our purpose was to evaluate the safety and efficacy of EPBD for bile duct stones in patients of 85 years of age and older.
Retrospective study from a single center.
Tertiary care facility with experience in bile duct stone removal with EPBD.
A total of 406 patients (74 patients >/=85 years old, group A; 332 patients <85 years old, group B) with bile duct stones underwent EPBD.
Efficacy and safety of EPBD between the 2 groups. Baseline patient characteristics were also evaluated.
The mean American Society of Anesthesiologists score in group A was significantly higher compared with that in group B (2.4 [0.5] vs 1.9 [0.7], P < .0001). Patients received anticoagulants more frequently and had larger and more numerous stones in group A than in group B with significant differences. Overall, bile duct clearance rates were similar in the 2 groups (91% vs 95%), but the mean number of sessions required for complete stone removal was significantly higher in group A (1.6 vs 1.4, P = .0081). The incidence of overall early complications after EPBD was lower in group A than in group B (2.7% vs 8.4%) but was not statistically different. None of the patients in group A had post-EPBD pancreatitis, whereas pancreatitis occurred in 5.7% in group B (P = .036). Bleeding was not observed after EPBD in 406 patients, including 7 patients in group A who received anticoagulation therapy at the time of EPBD. There was no significant difference in the cumulative stone nonrecurrence rate between group A and group B (log-rank test, P = .6225).
EPBD is a safe and effective technique for the treatment of bile duct stones even in high-risk elderly patients without an increased risk of pancreatitis and bleeding. Because the evaluation of outcomes might be biased by our study design (an open study), further studies are needed.
内镜下乳头球囊扩张术(EPBD)是治疗胆管结石的一种可能替代内镜括约肌切开术的方法。然而,关于老年患者的相关信息较少。
我们的目的是评估EPBD治疗85岁及以上患者胆管结石的安全性和有效性。
来自单一中心的回顾性研究。
在使用EPBD进行胆管结石清除方面有经验的三级医疗设施。
共有406例胆管结石患者接受了EPBD治疗(74例年龄≥85岁,A组;332例年龄<85岁,B组)。
两组之间EPBD的有效性和安全性。还评估了患者的基线特征。
A组美国麻醉医师协会平均评分显著高于B组(2.4 [0.5] 对1.9 [0.7],P <.0001)。A组患者接受抗凝治疗的频率更高,结石更大、数量更多,与B组相比有显著差异。总体而言,两组的胆管清除率相似(91%对95%),但A组完全清除结石所需的平均次数显著更高(1.6对1.4,P =.0081)。EPBD后总体早期并发症的发生率A组低于B组(2.7%对8.4%),但无统计学差异。A组患者术后均未发生胰腺炎,而B组胰腺炎发生率为5.7%(P =.036)。406例患者EPBD后均未观察到出血,包括A组7例在EPBD时接受抗凝治疗的患者。A组和B组之间的累积结石无复发率无显著差异(对数秩检验,P =.6225)。
即使在高危老年患者中,EPBD也是治疗胆管结石的一种安全有效的技术,且胰腺炎和出血风险没有增加。由于我们的研究设计(一项开放性研究)可能会使结果评估产生偏差,因此需要进一步研究。